Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMSC and Corticosteroids for Early Treatment of Acute GVHD
NCT02379442Phase 2Terminated
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Feb 2015
- Primary completion
- Dec 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in Acute Graft-Versus-Host Disease (aGVHD), sponsored by National Heart, Lung, and Blood Institute. Started Feb 2015; status: terminated.
02
Drugs
mesenchymal stem cells
03
Conditions
Acute Graft-Versus-Host Disease (aGVHD)
Beyond the preview
Go deeper on NCT02379442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02379442.